Related Experiment Video
Updated: Jul 7, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Celiac Disease in Moroccan Children: Diagnostic Characteristics and Determinants of Diagnosis Delay
Assia Mouslih1, Karima El Rhazi1, Nassiba Bahra1
1Laboratory of Epidemiology and Health Research, Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University, Fez, MAR.
Insights
Diagnosis of celiac disease in Moroccan children is often delayed, with symptom onset age and diagnosis age significantly impacting the timeline. Early awareness and diagnosis strategies are crucial for better outcomes.
Area of Science:
- Pediatrics
- Gastroenterology
- Public Health
Background:
- Celiac disease remains underdiagnosed globally.
- Timely diagnosis is challenging for clinicians.
- Understanding diagnosis patterns in specific populations is vital.
Purpose of the Study:
- To analyze celiac disease diagnosis characteristics in Moroccan children.
- To determine the diagnosis delay and influencing factors.
- To inform strategies for earlier detection.
Main Methods:
- Retrospective study of 324 children diagnosed between 2010-2019 in Fez, Morocco.
- Data collected via a grid and analyzed using SPSS.
- Multivariate logistic regression used to identify factors associated with delayed diagnosis.
Main Results:
- Mean diagnosis delay was 22.2 months; only 32.7% diagnosed within 12 months.
- Diarrhea and growth delay were common symptoms; pediatrician was the first point of contact for 50.5%.
- Late diagnosis was associated with increased symptom onset age and diagnosis age.
Conclusions:
- Significant delays in celiac disease diagnosis exist in Moroccan children.
- Awareness among healthcare professionals is needed to identify cases earlier.
- Improved diagnostic strategies can reduce adverse effects and complications.
Abstract:
Advances in the field of celiac disease have led to a better understanding of the disease, but it remains underdiagnosed and poses a daily challenge to clinicians to make a timely diagnosis. This study aims to analyze and describe diagnosis characteristics, diagnosis delay, and the factors influencing this delay in Moroccan children. Our study included 324 children diagnosed during the study period from January 01, 2010, to December 30, 2019, at the Department of Pediatrics, Hassan II University Hospital in Fez, Morocco. Data were collected using a collection grid and then analyzed using SPSS 26 software (IBM Corp., Armonk, NY). The results showed a female predominance (n=197, 60.8%), with a diagnosis age of 73.8±46.8 months. The mean age onset of symptoms was 51.3±41.2 months, and the diagnosis delay was 22.2±22.6 months, with only 32.7% (n=106) diagnosed less than 12 months after symptom onset. The most common consultation reason was diarrhea (n=149, 46%) and growth delay (n=105, 32.4%) and 50.5% (n=98) of parents consulted a pediatrician first. The three clinical, serologic, and histologic criteria made it possible to agree on the diagnosis, with the clinical profile dominated by the digestive form at 84.9% (n=279), serologic with the presence of IgA transglutaminase antibodies (95.7%; n=310), and histologic with villous atrophy at 91.7% (n=297). Unfortunately, 14.8% (n=48) of the children were diagnosed with a celiac crisis. The multivariate logistic regression analysis showed that as symptoms onset age increased, so did the risk of late diagnosis (OR=0.96, 95% CI: 0.94 to 0.97, p<0.001). Age of diagnosis was also associated with delayed diagnosis (OR=19.68, 95% CI: 8.77 to 44.15, p<0.001). The combination of these variables and the diagnosis delay argues in favor of adopting a diagnosis strategy that includes raising awareness among healthcare professionals of the need to identify typical and atypical cases early in order to reduce the adverse effects of late diagnosis and the complications that can result. This methodology for improving diagnoses may also unearth previously unknown aspects of celiac disease in Moroccan children.
More Related Videos
05:45Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
08:23Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diabetes: Symptoms, Diagnosis, and Complications
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: